<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:23:08Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10251685" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10251685</identifier>
        <datestamp>2023-06-10</datestamp>
        <setSpec>bmchsr</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Health Serv Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Health Serv Res</journal-id>
              <journal-title-group>
                <journal-title>BMC Health Services Research</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1472-6963</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10251685</article-id>
              <article-id pub-id-type="pmcid">PMC10251685</article-id>
              <article-id pub-id-type="pmc-uid">10251685</article-id>
              <article-id pub-id-type="pmid">37291599</article-id>
              <article-id pub-id-type="pmid">37291599</article-id>
              <article-id pub-id-type="publisher-id">9468</article-id>
              <article-id pub-id-type="doi">10.1186/s12913-023-09468-7</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chapdelaine</surname>
                    <given-names>Alexandra</given-names>
                  </name>
                  <address>
                    <email>Alexandra.Chapdelaine@usherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Vasiliadis</surname>
                    <given-names>Helen-Maria</given-names>
                  </name>
                  <address>
                    <email>Helen-Maria.Vasiliadis@usherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Provencher</surname>
                    <given-names>Martin D.</given-names>
                  </name>
                  <address>
                    <email>Martin.Provencher@psy.ulaval.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Norton</surname>
                    <given-names>Peter J.</given-names>
                  </name>
                  <address>
                    <email>Peter.Norton@cairnmillar.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Roberge</surname>
                    <given-names>Pasquale</given-names>
                  </name>
                  <address>
                    <email>Pasquale.Roberge@usherbrooke.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution>PRIMUS Research Group, Faculty of Medicine and Health Sciences, </institution><institution>Université de Sherbrooke, </institution></institution-wrap>3001 12e Avenue N, Sherbrooke, Québec J1H 5N4 Canada </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution>Department of Community Health Sciences, Faculty of Medicine and Health Sciences, </institution><institution>Université de Sherbrooke - Campus de Longueuil, </institution></institution-wrap>150 Place Charles-Le Moyne, Longueuil, Québec J4K 0A8 Canada </aff>
                <aff id="Aff3"><label>3</label>Centre de Recherche Charles-Le Moyne, 150 Place Charles-Le Moyne, Longueuil, Québec J4K 0A8 Canada </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.23856.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8390</institution-id><institution>École de psychologie, </institution><institution>Université Laval, </institution></institution-wrap>Pavillon Félix-Antoine-Savard, 2325 All. des Bibliothèques, Québec, Québec G1V 0A6 Canada </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.498570.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 9849 4459</institution-id><institution>The Cairnmillar Institute, </institution></institution-wrap>391-393 Tooronga Road, Hawthorn East, Victoria, VIC 3123 Australia </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.86715.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 6198</institution-id><institution>Department of Family Medicine and Emergency Medicine, Faculty of Medicine and Health Sciences, </institution><institution>Université de Sherbrooke, </institution></institution-wrap>3001 12e Avenue N, Sherbrooke, Québec J1H 5N4 Canada </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.411172.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0081 2808</institution-id><institution>Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), </institution></institution-wrap>3001 12e Avenue N, Sherbrooke, Québec J1H 5N4 Canada </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>8</day>
                <month>6</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>8</day>
                <month>6</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>23</volume>
              <elocation-id>596</elocation-id>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>28</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2023</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Access to evidence-based psychological treatment is a concern in many parts of the globe due to government-level financial constraints and patient-level barriers. Transdiagnostic cognitive behavioural therapy (tCBT) is an effective treatment approach that uses a single protocol for anxiety disorders which could enhance the dissemination of evidence-based psychotherapy. In a context of limited resources, the study of treatment moderators can allow to identify subgroups for which the cost-effectiveness of an intervention differs, information that could impact decision-making. So far, there has been no economic evaluation of tCBT for different subpopulations. The objectives of this study, using the net-benefit regression framework, were to explore clinical and sociodemographic factors as potential moderators of the cost-effectiveness of tCBT compared to treatment-as-usual (TAU).</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">This is a secondary data analysis of a pragmatic randomized controlled trial opposing tCBT added to TAU (n = 117) to TAU only (n = 114). Data on costs from the health system and the limited societal perspectives, as well as anxiety-free days, an effectiveness measure based on the Beck Anxiety Inventory, were collected over an 8-month time horizon and used to derive individual net-benefits. The net-benefit regression framework was used to assess moderators of the cost-effectiveness of tCBT + TAU as opposed to TAU alone. Variables of sociodemographic and clinical nature were assessed.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Results showed that the number of comorbid anxiety disorders significantly moderated the cost-effectiveness of tCBT + TAU compared to TAU from the limited societal perspective.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">The number of comorbid anxiety disorders was identified as a moderator affecting the cost-effectiveness of tCBT + TAU compared to TAU from the limited societal perspective. More research is needed to strengthen the case of tCBT from an economic standpoint for large-scale dissemination.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par5">ClinicalTrials.gov: NCT02811458, 23/06/2016</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s12913-023-09468-7.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Transdiagnostic</kwd>
                <kwd>Cognitive behaviour therapy</kwd>
                <kwd>Anxiety disorders</kwd>
                <kwd>Group psychotherapy</kwd>
                <kwd>Health care economics</kwd>
                <kwd>Net-benefit regression framework</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000156</institution-id>
                      <institution>Fonds de Recherche du Québec - Santé</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>254786</award-id>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id>
                      <institution>Canadian Institutes of Health Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>334091</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par6">In reimbursement decisions and resource allocation, decision-makers often rely on data from economic evaluations, which is the comparative analysis of alternative interventions in terms of both their costs and consequences [<xref ref-type="bibr" rid="CR1">1</xref>]. The incremental cost-effectiveness ratio (ICER) is a standard calculation in economic evaluations which represents the difference in mean cost (ΔC) between two interventions divided by the difference in mean effectiveness (ΔE). The ICER has several limitations, which can be addressed with the net-benefit regression framework [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Notably, the information given by the ICER without a cost-effectiveness plane is limited in regard to its interpretability. A positive ICER can indicate a scenario where an intervention is less effective and less costly or a situation where an intervention is both more effective and costlier. From a statistical point of view, this also leads to interpretation issues when the uncertainty surrounding the ICER covers more than one quadrant on a cost-effectiveness plane or when comparing an ICER to a threshold [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Further to this, researchers explain how the willingness to pay (WTP) is usually unknown [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. As has been described, the incremental net-benefit (INB) is a linear reformulation of the ICER that incorporates the WTP and is calculated as: λ*ΔE-ΔC, where λ is a willingness to pay threshold, and can be interpreted as cost-effective if positive [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Exploring different variations of the WTP using the net-benefit approach allows for a better understanding of the effect of different WTP thresholds on the cost-effectiveness of an intervention [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Moreover, the linear rearrangement of the ICER into the net-benefit allows for linear regression modeling and therefore offers the possibility to control for potential confounding factors and identify subgroups for which an intervention could be more or less cost-effective [<xref ref-type="bibr" rid="CR3">3</xref>]. This approach can help inform decision-making in implementing an intervention or optimizing care trajectories when resources are limited, such as in the mental health sector.</p>
              <p id="Par7">Cognitive behavioural therapy (CBT) is the most recommended psychotherapy for anxiety disorders [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Transdiagnostic cognitive behavioural therapy (tCBT) for anxiety disorders uses a single protocol to treat various anxiety disorders. It builds on the commonalities between recommended CBT protocols for anxiety disorders [<xref ref-type="bibr" rid="CR10">10</xref>]. Some authors have highlighted the benefits of tCBT for anxiety disorders. In particular, they emphasize the reduced need for training for therapists who want to work with individuals with different type of anxiety disorders. It also aids the dissemination of group psychotherapy as this protocol allows for a heterogeneous clientele [<xref ref-type="bibr" rid="CR10">10</xref>]. tCBT for anxiety disorders has been found effective in multiple meta-analyses when compared with passive as well as active controls such as diagnosis-specific CBT [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR15">15</xref>]. Determining the potential moderators of the cost-effectiveness of tCBT is important. Identifying moderators may provide information on subpopulations for which tCBT may be more or less cost-effective, optimizing health care trajectories.</p>
              <p id="Par8">The rare economic evaluations of psychotherapy for adults with common mental disorders that have used the net-benefit regression framework have adjusted their analytic models for factors including: total societal costs, age, sex, health-related quality of life, symptom severity, cancer, and comorbid neurological disorders at baseline [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Evaluating the cost-effectiveness of CBT for anxiety disorders, Egger et al., (2015, 2016) adjusted their net-benefit regression model for gender, comorbid mental disorders, employment status, study sites, age, clinical index, baseline costs, and group psychotherapists delivering the intervention [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. None of these cost-effectiveness studies justified adjusting for these variables nor included an analysis of their potential impact as moderators.</p>
              <p id="Par9">While potential moderators relating to the cost-effectiveness of CBT are not well specified, predictors and moderators of treatment outcomes related to CBT for common mental disorders have included sociodemographic and clinical factors [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR23">23</xref>]. The literature however on the sociodemographic and clinical factors associated with tCBT-related outcomes is scarce. Recently, Gonzáles-Blanch et al., (2021) assessed general predictors and moderators of treatment outcome in tCBT compared to treatment-as-usual (TAU) for emotional disorders. In their exploratory analysis, among the sociodemographic factors, marital status and employment status moderated the association between the intervention and treatment outcome (score on the seven-item Generalized Anxiety Disorder scale (GAD-7)) [<xref ref-type="bibr" rid="CR24">24</xref>]. The presence of anxiety and depression comorbidity and baseline severity moderated the association among the clinical variables assessed. Compared to TAU, tCBT had a greater positive effect in individuals with comorbidity and higher symptom severity at baseline. The intervention however seemed less beneficial for those taking antidepressants at baseline than those who did not [<xref ref-type="bibr" rid="CR24">24</xref>]. As for related costs, some found a decrease in overall and mental health care costs after CBT for anxiety disorders, but potential moderators were not identified [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
              <p id="Par10">A number of the studies on CBT and tCBT [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR24">24</xref>] took place in Germany and Spain, where although psychological services are covered or reimbursed by the healthcare system, long waiting lists are an issue. Similarly, in Quebec, Canada, where the public healthcare system covers most medical services for residents; long waiting lists have been described for psychological services [<xref ref-type="bibr" rid="CR27">27</xref>]. For those who cannot afford private psychological services and rely on public services, timely access to care is of concern. In a context of limited financial and human resources [<xref ref-type="bibr" rid="CR28">28</xref>], tCBT could prove beneficial [<xref ref-type="bibr" rid="CR10">10</xref>]. In a recent paper, we showed that there was a probability of ≥95% that tCBT added to treatment as usual was cost-effective compared to treatment as usual from the health system and limited societal perspectives at a WTP of $25/anxiety-free day and $40/anxiety-free day over an 8-month time horizon, respectively [<xref ref-type="bibr" rid="CR29">29</xref>]. Identifying subgroups however for which tCBT is cost-effective may further help optimize the allocation of resources and improve the value of mental health care. In this secondary data analysis, we therefore aimed to conduct a net-benefit regression analysis [<xref ref-type="bibr" rid="CR3">3</xref>] to identify associated moderators of the cost-effectiveness of group tCBT [<xref ref-type="bibr" rid="CR30">30</xref>] added to TAU compared to TAU only for adults with anxiety disorders in the province of Quebec, Canada.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Sample</title>
                <p id="Par11">The data used in this study are from a 12-month multi-centered, single-blinded, pragmatic randomized controlled trial, which aimed to evaluate the effectiveness of tCBT + TAU (n = 117) compared to TAU alone (n = 114) in the province of Quebec [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Randomization was stratified 1:1 by study sites with blocking. The study took place in community-based care settings in three health administrative regions. Participants self-referred to the study through ads in social media, regional newspapers, and bulletin boards. The inclusion criteria were: (1) aged 18–65; (2) fluent in spoken and written French; and (3) meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [<xref ref-type="bibr" rid="CR33">33</xref>] criteria for panic disorder (PD), agoraphobia (AGO), social anxiety disorder (SAD) and/or generalized anxiety disorder (GAD), with a clinical severity rating (CSR) ≥ 4 on the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5) [<xref ref-type="bibr" rid="CR34">34</xref>]. The principal anxiety disorder was defined as the one with the higher CSR rating. If there was a similar rating, clinical judgement was used to make the final decision. Exclusion criteria included the presence of either active suicidal intent, psychosis, bipolar disorder, substance-related and addictive disorders, cognitive impairment, and consultation with a psychiatrist in the past 12 months.</p>
              </sec>
              <sec id="Sec4">
                <title>Interventions</title>
                <p id="Par12">The tCBT intervention was provided during 12 weekly 2-hour group sessions co-led by two certified therapists. Groups generally included ten participants. The treatment protocol focused on CBT components: (1) education and self-monitoring, (2) specific cognitive restructuring, (3) graduated exposure and response prevention, and (4) generalized cognitive restructuring (i.e., focus on more general anxious style) [<xref ref-type="bibr" rid="CR30">30</xref>]. Compared to conventional CBT, tCBT uses only one treatment protocol to simultaneously address a range of anxiety disorders by targeting common cognitive and behavioural processes with recurring elements of more specific CBT protocols [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
                <p id="Par13">Participants, both in the tCBT + TAU and TAU groups, given the pragmatic design, could stop or start any new treatment during the study period, and there was no restriction on the type of treatments received (e.g., psychotherapy [including CBT], pharmacotherapy, alternative and complementary medicines). For TAU, it was possible for participants to receive no treatment for their anxiety disorder.</p>
              </sec>
              <sec id="Sec5">
                <title>Economic evaluation</title>
                <sec id="Sec314">
                  <title>Data collection</title>
                  <p id="Par15">For this analysis, three data points were considered over an 8-month time horizon: baseline (T<sub>0</sub>), post-treatment (T<sub>1</sub>: 4 months after randomization), and 4-month post-treatment (T<sub>2</sub>: 8 months after randomization). The time horizon being less than one year, no discount rates were applied. Data were collected during in-person (T<sub>0,</sub> T<sub>1</sub>) and telephone (T<sub>2</sub>) assessments. All participants provided written consent.</p>
                </sec>
                <sec id="Sec6">
                  <title>Mental health service use and costs</title>
                  <p id="Par16">The methodology for this economic evaluation has been described in detail elsewhere [<xref ref-type="bibr" rid="CR29">29</xref>]. Briefly, health service use data for mental health reasons were collected retrospectively, over the past four months since the current assessment, with a structured interview guide [<xref ref-type="bibr" rid="CR35">35</xref>]. Self-reported data on mental health related medical and social services used in an outpatient setting (in the public and the private sector), emergency department visits, inpatient stays, and outpatient medications delivered were considered as well as information on time spent on medical appointments, transportation to and from medical appointments, day-to-day assistance, work productivity (long-term sick leave and presenteeism) and the use of alternative and complementary medicine, all for mental health reasons. The cost of the tCBT intervention was estimated based on sessions being led by one therapist from the public sector and one therapist from the private sector. It included therapist fees (time in session and preparation, phone follow-up, individual pre-therapy appointment), general overhead costs, and supporting documents for participants.</p>
                  <p id="Par17">The health system and the limited societal [<xref ref-type="bibr" rid="CR36">36</xref>] perspectives were considered. No data was available on costs from the criminal justice and education sectors. For costs incurred by the public healthcare system, a direct allocation method was used based on annual financial and activity reports of health establishments in Quebec, submitted to the Quebec Ministry of Health and Social Services [<xref ref-type="bibr" rid="CR37">37</xref>]. Costs were valued in 2020 Canadian dollars currency ($CAN) after adjustment with the Canadian consumer price index for January 2020 in Quebec [<xref ref-type="bibr" rid="CR38">38</xref>]. For more detail on costing and cost data sources, see the Supplementary Methods Appendix <xref rid="MOESM1" ref-type="media">1</xref>.</p>
                </sec>
                <sec id="Sec7">
                  <title>Effectiveness outcome</title>
                  <p id="Par18">Effectiveness was evaluated using Anxiety-Free Days (AFDs), a concept first introduced as an outcome for depression by Lave et al., (1998) [<xref ref-type="bibr" rid="CR39">39</xref>]. It is a summary outcome of symptoms variation over time [<xref ref-type="bibr" rid="CR39">39</xref>] that is valid and easily interpreted [<xref ref-type="bibr" rid="CR40">40</xref>]. The Beck Anxiety Inventory (BAI) [<xref ref-type="bibr" rid="CR41">41</xref>] was used to elicit AFDs as it is not specific to a particular anxiety disorder. An AFD value was computed at each assessment. Based on the BAI, a score of 7 or less, corresponding to the minimal anxiety cut-off, was considered a day free of anxiety (1 AFD). A score of 26 or more on the BAI (severe anxiety cut-off) was considered a day with anxiety (0 AFD). For scores in-between, values were weighted accordingly. Linear interpolation was used to assess the number of AFDs between each assessment (T<sub>0</sub>-T<sub>1</sub>, T<sub>1</sub>-T<sub>2</sub>). The number of AFDs per period was summed to cover the 8-month time horizon (T<sub>0</sub>-T<sub>2</sub>). Consequently, the range of possible AFDs was 0 to 244.</p>
                </sec>
              </sec>
              <sec id="Sec219">
                <title>Individual-level characteristics</title>
                <p id="Par20">Factors potentially associated with mental health-related costs (e.g., direct medical costs, indirect medical costs, and indirect costs including work productivity) and/or effectiveness of tCBT and CBT according to the literature were considered for this analysis. Sociodemographic factors considered included: age (continuous variable), sex (male, female), marital status (in a relationship, single/separated/widowed) [<xref ref-type="bibr" rid="CR24">24</xref>], occupation (works full-time, works part-time, non-remunerated, sick leave) [<xref ref-type="bibr" rid="CR24">24</xref>], education (high school or less, collegial or vocational, university) [<xref ref-type="bibr" rid="CR42">42</xref>], and self-perceived economic status (at ease, sufficient, poor or worse) [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. Health system factors considered included: complementary private health insurance (yes, no), covered under a private medication insurance plan (yes, no) [<xref ref-type="bibr" rid="CR46">46</xref>], and having a family practitioner (yes, no) [<xref ref-type="bibr" rid="CR49">49</xref>]. Clinical factors studied included: the presence of comorbid major depression (yes, no) [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR52">52</xref>], the presence of comorbid anxiety disorders (none, one, two, three based on the inclusion criteria [GAD, SAD, AGO, PD]) [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>], anxiety symptom severity at baseline (continuous variable) [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], self-perceived mental health (excellent/very good, good, average or less) [<xref ref-type="bibr" rid="CR54">54</xref>], self-perceived physical health (excellent/very good, good, average or less) [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>], taking psychotropic medication (yes, no) [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR57">57</xref>] and other ADIS-5 mental health comorbidities (those with at least one count in the current sample: dysthymia, specific phobia, post-traumatic stress disorder, obsessive-compulsive disorder, major depression) (yes, no) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>] were considered.</p>
              </sec>
              <sec id="Sec221">
                <title>Statistics</title>
                <sec id="Sec8">
                  <title>Missing data</title>
                  <p id="Par22">On the assumption of a ‘Missing at Random’ mechanism, cost and clinical outcomes were imputed with Amelia II multiple imputation R package, which uses a bootstrapping-based expectation-maximization algorithm that is appropriate for longitudinal, continuous, and categorical data [<xref ref-type="bibr" rid="CR58">58</xref>]. Variables with a skewed distribution were not transformed and the imputation model was not restricted by logical bounds [<xref ref-type="bibr" rid="CR59">59</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. Twenty datasets were imputed, and the imputation model included baseline variables associated with the probability of missing data. The pooling method for the linear regression estimates was based on Rubin’s rule and provided by SPSS [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
                </sec>
                <sec id="Sec9">
                  <title>Net-benefit regression framework</title>
                  <p id="Par23">The net-benefit regression framework incorporates the notion of willingness to pay threshold (WTP, λ) in a linear reorganization of the ICER where the INB is equal to <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\mu }}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq1.gif"/></alternatives></inline-formula>ΔEλ-<inline-formula id="IEq2"><alternatives><tex-math id="M2">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\mu }}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq2.gif"/></alternatives></inline-formula>ΔC. If the INB is positive, the new intervention is deemed cost-effective because the monetary value of its effect outweighs its cost at a determined WTP. Its statistical properties [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>] makes it suitable for linear regression analysis by defining an individual (<sub>i</sub>) net-benefit (<inline-formula id="IEq3"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{n}\text{b}}_{\text{i}})$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq3.gif"/></alternatives></inline-formula> for each participant: <inline-formula id="IEq4"><alternatives><tex-math id="M4">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\text{n}\text{b}}_{\text{i}}}={{\lambda }\widehat{\text{E}}}_{\text{i}}-\widehat{{\text{C}}_{\text{i}}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq4.gif"/></alternatives></inline-formula>. A basic linear net-benefit regression model would be: <inline-formula id="IEq5"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\text{n}\text{b}}_{\text{i}}}=\widehat{{\beta }}\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}+{\alpha }$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq5.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq6"><alternatives><tex-math id="M6">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\beta }}\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq6.gif"/></alternatives></inline-formula> is the <inline-formula id="IEq7"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{\text{I}\text{N}\text{B}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq7.gif"/></alternatives></inline-formula>. This regression framework allows adjusting for potential confounders and moderators [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. At WTP = $0/AFD, the <inline-formula id="IEq8"><alternatives><tex-math id="M8">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\text{n}\text{b}}_{\text{i}}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq8.gif"/></alternatives></inline-formula> is reduced to <inline-formula id="IEq9"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$-\widehat{{\text{C}}_{\text{i}}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq9.gif"/></alternatives></inline-formula>; <inline-formula id="IEq10"><alternatives><tex-math id="M10">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{\text{I}\text{N}\text{B}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq10.gif"/></alternatives></inline-formula> becomes <inline-formula id="IEq11"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{-{\Delta }\text{C}}\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq11.gif"/></alternatives></inline-formula>. With increasing WTP, there is a greater emphasis on<inline-formula id="IEq12"><alternatives><tex-math id="M12">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\widehat{ \text{E}}}_{\text{i}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq12.gif"/></alternatives></inline-formula>, which eventually will tend towards infinity, and <inline-formula id="IEq13"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{\text{I}\text{N}\text{B}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq13.gif"/></alternatives></inline-formula> will become <inline-formula id="IEq14"><alternatives><tex-math id="M14">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\Delta }\text{E}}\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq14.gif"/></alternatives></inline-formula>.</p>
                  <p id="Par24">The new intervention’s adjusted cost-effectiveness probability is the one-sided p-value associated with the hypothesis that <inline-formula id="IEq15"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\beta }}\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}&gt;0$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq15.gif"/></alternatives></inline-formula>. It is used to create a CEAC for different WTP thresholds [<xref ref-type="bibr" rid="CR63">63</xref>]. To do so, a graph was generated by plotting the one-sided p-values on the y-axis, which is the probability of cost-effectiveness, obtained at a range of WTP from $0/AFD to $100/AFD (x-axis). A probability threshold of 95% was used to determine if tCBT+TAU would be cost-effective compared to TAU alone. In Table <xref rid="Tab1" ref-type="table">1</xref>, bilateral p-values are presented.</p>
                  <p id="Par25">
                    <table-wrap id="Tab1">
                      <label>Table 1</label>
                      <caption>
                        <p>Number of comorbid anxiety disorders as the moderator of the cost-effectiveness of tCBT + TAU compared to TAU as shown by multivariable linear regression</p>
                      </caption>
                      <table frame="hsides" rules="groups">
                        <thead>
                          <tr>
                            <th align="left"/>
                            <th align="left" colspan="26">Willingness to pay threshold ($CAN)</th>
                          </tr>
                          <tr>
                            <th align="left"/>
                            <th align="left" colspan="3">WTP (0)</th>
                            <th align="left" colspan="3">WTP (10)</th>
                            <th align="left" colspan="3">WTP (20)</th>
                            <th align="left" colspan="3">WTP (30)</th>
                            <th align="left" colspan="3">WTP (40)</th>
                            <th align="left" colspan="4">WTP (50)</th>
                            <th align="left" colspan="3">WTP (60)</th>
                            <th align="left" colspan="3">WTP (80)</th>
                            <th align="left">WTP (100)</th>
                          </tr>
                          <tr>
                            <th align="left"/>
                            <th align="left" colspan="26">
                              <inline-formula id="IEq16">
                                <alternatives>
                                  <tex-math id="M16">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{\beta }$$\end{document}</tex-math>
                                  <inline-graphic xlink:href="12913_2023_9468_Article_IEq16.gif"/>
                                </alternatives>
                              </inline-formula>
                            </th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left">
                              <bold>tCBT intervention (ref: TAU)</bold>
                              <sup>
                                <bold>a</bold>
                              </sup>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-2 199</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 855</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 511</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 167</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-823</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>-479</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-135</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>553</italic>
                            </td>
                            <td align="left">
                              <italic>1 241</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.088</td>
                            <td align="left" colspan="3">0.157</td>
                            <td align="left" colspan="3">0.265</td>
                            <td align="left" colspan="3">0.411</td>
                            <td align="left" colspan="3">0.584</td>
                            <td align="left" colspan="4">0.765</td>
                            <td align="left" colspan="3">0.937</td>
                            <td align="left" colspan="3">0.778</td>
                            <td align="left">0.579</td>
                          </tr>
                          <tr>
                            <td align="left" colspan="2">
                              <p>
                                <bold>Number of comorbid anxiety</bold>
                              </p>
                              <p>
                                <bold>disorders (ref: none)</bold>
                              </p>
                            </td>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="2"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="2"/>
                          </tr>
                          <tr>
                            <td align="left">One</td>
                            <td align="left" colspan="3">
                              <italic>-663</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-926</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 188</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 451</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 714</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>-1 977</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-2 240</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-2 765</italic>
                            </td>
                            <td align="left">
                              <italic>-3 291</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.553</td>
                            <td align="left" colspan="3">0.417</td>
                            <td align="left" colspan="3">0.316</td>
                            <td align="left" colspan="3">0.245</td>
                            <td align="left" colspan="3">0.196</td>
                            <td align="left" colspan="4">0.163</td>
                            <td align="left" colspan="3">0.140</td>
                            <td align="left" colspan="3">0.113</td>
                            <td align="left">0.099</td>
                          </tr>
                          <tr>
                            <td align="left">Two</td>
                            <td align="left" colspan="3">
                              <italic>-1 430</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 711</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-1 991</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-2 271</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-2 552</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>-2 832</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-3 112</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-3 673</italic>
                            </td>
                            <td align="left">
                              <italic>-4 234</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.310</td>
                            <td align="left" colspan="3">0.233</td>
                            <td align="left" colspan="3">0.179</td>
                            <td align="left" colspan="3">0.143</td>
                            <td align="left" colspan="3">0.120</td>
                            <td align="left" colspan="4">0.105</td>
                            <td align="left" colspan="3">0.095</td>
                            <td align="left" colspan="3">0.084</td>
                            <td align="left">0.080</td>
                          </tr>
                          <tr>
                            <td align="left">Three</td>
                            <td align="left" colspan="3">
                              <italic>-4 964</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-5 684</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-6 403</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-7 123</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-7 842</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>-8 562</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-9 282</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>-10 721</italic>
                            </td>
                            <td align="left">
                              <italic>-12 160</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.015</td>
                            <td align="left" colspan="3">0.007</td>
                            <td align="left" colspan="3">0.003</td>
                            <td align="left" colspan="3">0.002</td>
                            <td align="left" colspan="3">0.001</td>
                            <td align="left" colspan="4">0.001</td>
                            <td align="left" colspan="3">0.001</td>
                            <td align="left" colspan="3">0.001</td>
                            <td align="left">0.001</td>
                          </tr>
                          <tr>
                            <td align="left">
                              <bold>Intervention * nb of comorbid anxiety disorders (ref: TAU, none)</bold>
                              <sup>
                                <bold>a</bold>
                              </sup>
                            </td>
                            <td align="left" colspan="2"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                            <td align="left" colspan="3"/>
                          </tr>
                          <tr>
                            <td align="left">tCBT + TAU * One</td>
                            <td align="left" colspan="3">
                              <italic>895</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>1 123</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>1 352</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>1 580</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>1 809</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>2 038</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>2 266</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>2 723</italic>
                            </td>
                            <td align="left">
                              <italic>3 181</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.586</td>
                            <td align="left" colspan="3">0.500</td>
                            <td align="left" colspan="3">0.432</td>
                            <td align="left" colspan="3">0.380</td>
                            <td align="left" colspan="3">0.342</td>
                            <td align="left" colspan="4">0.315</td>
                            <td align="left" colspan="3">0.295</td>
                            <td align="left" colspan="3">0.272</td>
                            <td align="left">0.261</td>
                          </tr>
                          <tr>
                            <td align="left">tCBT + TAU * Two</td>
                            <td align="left" colspan="3">
                              <italic>2 885</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>2 961</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>3 038</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>3 115</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>3 191</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>3 268</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>3 344</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>3 497</italic>
                            </td>
                            <td align="left">
                              <italic>3 650</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.143</td>
                            <td align="left" colspan="3">0.140</td>
                            <td align="left" colspan="3">0.143</td>
                            <td align="left" colspan="3">0.152</td>
                            <td align="left" colspan="3">0.165</td>
                            <td align="left" colspan="4">0.181</td>
                            <td align="left" colspan="3">0.200</td>
                            <td align="left" colspan="3">0.241</td>
                            <td align="left">0.283</td>
                          </tr>
                          <tr>
                            <td align="left">tCBT + TAU * Three</td>
                            <td align="left" colspan="3">
                              <italic>6 171</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>6 295</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>6 418</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>6 542</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>6 665</italic>
                            </td>
                            <td align="left" colspan="4">
                              <italic>6 789</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>6 912</italic>
                            </td>
                            <td align="left" colspan="3">
                              <italic>7 159</italic>
                            </td>
                            <td align="left">
                              <italic>7 406</italic>
                            </td>
                          </tr>
                          <tr>
                            <td align="left">p-value</td>
                            <td align="left" colspan="3">0.016</td>
                            <td align="left" colspan="3">0.016</td>
                            <td align="left" colspan="3">0.018</td>
                            <td align="left" colspan="3">0.022</td>
                            <td align="left" colspan="3">0.027</td>
                            <td align="left" colspan="4">0.035</td>
                            <td align="left" colspan="3">0.044</td>
                            <td align="left" colspan="3">0.068</td>
                            <td align="left">0.098</td>
                          </tr>
                        </tbody>
                      </table>
                      <table-wrap-foot>
                        <p>Note. ref = Reference category; TAU = Treatment as usual; tCBT = Transdiagnostic cognitive behavioural therapy; WTP = Willingness to pay threshold. Adjusted for SAD as a principal diagnosis and comorbid PD.</p>
                        <p><sup>a</sup> The beta coefficients represent the incremental net-benefit.</p>
                      </table-wrap-foot>
                    </table-wrap>
                  </p>
                </sec>
                <sec id="Sec10">
                  <title>Confounders and moderators</title>
                  <p id="Par26">First, a series of linear regression analyses were conducted to identify potential confounders, and moderators using the nb<sub>i</sub> as an outcome. All models included a potential confounder or a moderator, and the intervention group as independent variables. Significant confounders or moderators were added simultaneously to the multivariable models. To be considered a confounder, a variable had to: (1) differ statistically between the two conditions (p-value of the pooled <inline-formula id="IEq17"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{\beta }$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq17.gif"/></alternatives></inline-formula>&lt;0.05) [<xref ref-type="bibr" rid="CR64">64</xref>]; (2) cause a 10% change in the beta estimate of the relationship between the intervention group and the outcome when added to the univariate model [<xref ref-type="bibr" rid="CR65">65</xref>]; as well as (3) be associated (p-value of the pooled <inline-formula id="IEq18"><alternatives><tex-math id="M18">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{\beta }$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq18.gif"/></alternatives></inline-formula>&lt;0.05) with the outcome [<xref ref-type="bibr" rid="CR64">64</xref>]. As for moderation analysis, the following basic model was used: <inline-formula id="IEq19"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\text{n}\text{b}}_{\text{i}}}=\widehat{{{\beta }}_{1}}\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}+\widehat{{{\beta }}_{2}}{\text{X}}_{2}+\widehat{{{\beta }}_{3}}\left(\text{I}\text{n}\text{t}\text{e}\text{r}\text{v}\text{e}\text{n}\text{t}\text{i}\text{o}\text{n}\text{*}{\text{X}}_{2}\right)+{\alpha }$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq19.gif"/></alternatives></inline-formula>. If p &lt; 0.05 for <inline-formula id="IEq20"><alternatives><tex-math id="M20">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{{\beta }}_{3}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq20.gif"/></alternatives></inline-formula> on at least one WTP threshold tested, <inline-formula id="IEq21"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{X}}_{2}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq21.gif"/></alternatives></inline-formula> was considered a potential moderator and was included in the multivariable models [<xref ref-type="bibr" rid="CR66">66</xref>]. The interaction term between the intervention group and moderating variables, <inline-formula id="IEq22"><alternatives><tex-math id="M22">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{{\beta }}_{3}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq22.gif"/></alternatives></inline-formula>, were used to represent the INB stratified by category of moderator. A stratified cost-effectiveness acceptability curve was provided for significant moderators.</p>
                </sec>
                <sec id="Sec11">
                  <title>Regression diagnostics and outliers</title>
                  <p id="Par27">The twenty datasets obtained by multiple imputation were checked individually [<xref ref-type="bibr" rid="CR67">67</xref>]. First, standardized residuals vs. standardized predicted value graphs were observed to find abnormal patterns indicating heteroscedasticity across datasets. A Loess curve with Cauchy kernels was fitted in the same graphs to assess the linearity of the relationships between the outcome and independent variables [<xref ref-type="bibr" rid="CR68">68</xref>]. Skewness and kurtosis parameters were assessed to evaluate the normality of the residuals. Z-values were obtained and compared against a threshold of 3.29 [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Variance inflation factors were computed and a threshold of 10 was considered for multicollinearity [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
                  <p id="Par28">Individuals with high leverage (Leverage &gt; 3*p/n [<xref ref-type="bibr" rid="CR72">72</xref>]; where p equals the number of variables including the constant) were investigated as well as those with absolute DFBETAS equal to or higher than <inline-formula id="IEq23"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2\surd \text{n}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq23.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR73">73</xref>]. Cook’s distance was also evaluated with a threshold of 4/n [<xref ref-type="bibr" rid="CR74">74</xref>]. Data points flagged as outliers or influential observations in five datasets or more were analyzed further to detect any recurring patterns in sociodemographic or clinical characteristics. A plot of standardized residuals vs. Leverage with Cook’s D at 4/n was created to identify influential outliers visually. A threshold of 1 was also considered [<xref ref-type="bibr" rid="CR75">75</xref>].</p>
                  <p id="Par29">In the final adjusted models, regression diagnostic showed a significant deviation from normality when WTP=$0/AFD, as expected due to the skewed nature of cost data (<inline-formula id="IEq24"><alternatives><tex-math id="M24">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{\text{n}\text{b}}_{\text{i}}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq24.gif"/></alternatives></inline-formula> reduced to <inline-formula id="IEq25"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\widehat{{-\text{C}}_{\text{i}}}$$\end{document}</tex-math><inline-graphic xlink:href="12913_2023_9468_Article_IEq25.gif"/></alternatives></inline-formula>),for the health system and the limited societal perspectives. Linearity was confirmed by examining the standardized residuals vs. fitted standardized predicted values based on Loess curve with Cauchy kernels. The homoscedasticity postulate was confirmed visually with graphs and using Levene’s test for homogeneity of variances with nb<sub>i</sub> as an outcome variable and this for both health system and limited societal economic perspectives. Some influential outliers were identified from the standardized residuals against leverage with Cook’s D contour plots. However, no clear pattern was derived from their baseline characteristics, and they were not constant between analyses at WTP=$0/AFD and WTP=$100/AFD. No outlier was removed from analyses, and no multicollinearity was detected in adjusted models. More detail can be found in the Supplementary Results Appendix <xref rid="MOESM2" ref-type="media">2</xref>.</p>
                  <p id="Par30">An alpha of 0.05 was used to determine statistical significance. IBM SPSS 24 was used to carry out the analysis following the intention-to-treat principle.</p>
                </sec>
              </sec>
            </sec>
            <sec id="Sec12" sec-type="results">
              <title>Results</title>
              <sec id="Sec13">
                <title>Baseline participant’s characteristics and missing data</title>
                <p id="Par31">A total of 117 participants were randomized to the tCBT + TAU condition and 114 participants in the TAU condition. At T<sub>1</sub>, respectively, in the tCBT + TAU and TAU conditions, 92 (78.6%) and 95 (83.3%) participants had an available BAI score and data on costs to proceed with the analysis. At T<sub>2</sub>, these numbers dropped to 87 (74.4%) and 90 (78.9%). Missing data were imputed. Since no logical bounds or transformations were applied, we examined the proportions of negative values for total cost after imputation. Across the 20 imputed datasets, from the health system perspective, the proportion of negative total cost data was 2.9%. From the limited societal perspective, this proportion amounted to 0.2%. More details on costs can be found in Chapdelaine et al. (2022) [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
                <p id="Par32">Participant characteristics have been described elsewhere [<xref ref-type="bibr" rid="CR32">32</xref>] and in the Supplementary Results Appendix (see Table <xref rid="MOESM2" ref-type="media">S1</xref>). Briefly, most of the sample consisted of women (85.7%), and the average age was 37 years old. Most participants worked full-time (60.6%) and considered themselves as being in a satisfactory economic situation (76.6%). Most participants had post-secondary education, and one-tenth had a high school degree or less. A third of participants considered themselves in very good or excellent physical health (34.2%). Half of the sample presented a GAD as a principal anxiety disorder (52.8%). Anxiety-anxiety comorbidity was high as three in four participants had at least one other comorbid anxiety disorder, the most frequent being SAD (33.8%). Close to one in four participants also had a comorbid major depressive disorder. Despite randomization, an imbalance remained in the prevalence of specific principal anxiety disorders between groups. In those randomized to tCBT + TAU, as compared to TAU, the proportion with a principal diagnosis of GAD was significantly higher while SAD was lower. There were also more individuals with comorbid PD in the tCBT + TAU group. As different types of anxiety disorders could lead to differences in healthcare utilization patterns [<xref ref-type="bibr" rid="CR76">76</xref>] and consequently potentially impact healthcare costs as well as symptomatology, these were considered as relevant control variables in the analyses.</p>
              </sec>
              <sec id="Sec14">
                <title>Confounders and moderators associated with the cost-effectiveness of tCBT</title>
                <p id="Par33">Table <xref rid="Tab1" ref-type="table">1</xref> shows the multivariable linear regression analyses of the nb<sub>i</sub> as a function of the identified confounders and moderators affecting the incremental net-benefit and therefore, the cost-effectiveness of tCBT. From the limited societal perspective, SAD as a principal diagnosis and comorbid PD were identified as confounding variables. There was a significant interaction between the intervention group and the number of comorbid anxiety disorders. It showed that compared to those with no comorbid anxiety disorders, for those with all four included anxiety disorders (GAD, PD, SAD, AGO), tCBT + TAU appeared cost-effective (p &lt; 0.05; WTP≤$60/AFD). The association was significant at a WTP=$0/AFD and indicated that compared to those with no comorbidity, those with three comorbid anxiety disorders in the control group had higher mental health costs than their counterparts in the intervention condition. Figure <xref rid="Fig1" ref-type="fig">1</xref> shows the CEAC stratified by the number of comorbid anxiety disorders. The probability of cost saving increases with the number of anxiety disorders (WTP=$0/AFD). Also, the probability of cost-effectiveness of tCBT + TAU increases with the number of anxiety disorders at WTP≤$50/AFD. At a threshold of $20/AFD, there was a 95% probability that tCBT + TAU would be cost-effective compared to TAU in those with three comorbid anxiety disorders. In those with no anxiety disorder comorbidity, the estimated probability was 12% at the same threshold.</p>
                <p id="Par333">
                  <fig id="Fig1">
                    <label>Fig. 1</label>
                    <caption>
                      <p>Limited societal perspective cost-effectiveness acceptability curve adjusted and stratified by the number of comorbid anxiety disorder</p>
                      <p><bold>Note</bold>. Models were stratified by anxiety-anxiety comorbidity with adjustment for having a social anxiety disorder as the principal diagnosis and having a comorbid panic disorder. Considered anxiety disorders are panic disorder, agoraphobia, social anxiety disorder and generalized anxiety disorder. ANX = anxiety disorder; TAU = Treatment as usual; tCBT = transdiagnostic cognitive behavioural therapy.</p>
                    </caption>
                    <graphic xlink:href="12913_2023_9468_Fig1_HTML" id="d32e1845"/>
                  </fig>
                </p>
                <p id="Par41">From the health system perspective, comorbid PD and, as principal diagnoses, SAD and GAD, were included in the multivariable model as potential confounders. From the health system perspective, none of the variables studied reached statistical significance as a moderator. The adjusted CEAC showed that at a WTP of $25/AFD, there was ≥ 95% of probability that tCBT + TAU would be cost-effective compared to TAU (See Table <xref rid="MOESM2" ref-type="media">S2</xref> and Figure <xref rid="MOESM2" ref-type="media">S1</xref> in the Supplementary Results).</p>
              </sec>
            </sec>
            <sec id="Sec15" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par42">Using data from an RCT opposing tCBT + TAU to TAU alone, this study aimed to identify moderators that could significantly affect the cost-effectiveness (i.e., the INB) of tCBT + TAU vs. TAU from the limited societal and health system perspectives. The probability of cost-effectiveness varied according to the number of anxiety comorbidities. tCBT + TAU had a 95% probability of being cost-effective versus TAU at a WTP=$20/AFD in those with three anxiety disorder comorbidities and 12% in those with no anxiety comorbidity. From the health system perspective, none of the interaction terms tested were significant.</p>
              <p id="Par43">The results showed that the number of comorbid anxiety disorders was a significant moderator of the association between the intervention group and the nb<sub>i</sub> from the limited societal perspective, supporting the use of tCBT in individuals with increasing comorbid anxiety disorders. Individuals in the tCBT + TAU group with more comorbidities had less mental health costs and more AFDs than those in the TAU group on the 8-month time horizon and, therefore, a higher probability of cost-effectiveness. These findings do not suggest that tCBT is not cost-effective for those with no comorbidity; it may be cost-effective but at a higher willingness to pay threshold.</p>
              <p id="Par44">The current findings complement those of Norton et al. (2021), from this same trial [<xref ref-type="bibr" rid="CR31">31</xref>], which showed that the rate of comorbidity (mainly between anxiety and major depressive disorder) was significantly lower from baseline to post-treatment and 8-month post-treatment in the tCBT + TAU condition compared to TAU, with comorbidity remission being defined as having no or subclinical symptom severity scores at evaluation [<xref ref-type="bibr" rid="CR77">77</xref>]. The latter results replicated those obtained in a previous efficacy trial on tCBT [<xref ref-type="bibr" rid="CR78">78</xref>]. Anxiety-anxiety comorbidities represent the norm [<xref ref-type="bibr" rid="CR79">79</xref>–<xref ref-type="bibr" rid="CR82">82</xref>] and have been associated with higher rates of chronicity, more severe depressive, anxiety and avoidance symptoms, and more social disability [<xref ref-type="bibr" rid="CR83">83</xref>]. tCBT could represent a cost-effective approach to alleviate the burden of individuals with comorbidities.</p>
              <p id="Par45">To our knowledge, there is a lack of literature on factors predicting change in health system and societal costs associated with health service utilization after treatment with CBT. The current findings showed an interaction between the intervention and the presence of anxiety disorder comorbidities. This suggests that comorbidities could moderate costs in CBT trials, and this finding will need further exploration.</p>
              <p id="Par46">Some limitations of the study need to be considered. First, it is noteworthy that the RCT on which the present study was based was powered for the primary outcome, which was the BAI score, and not cost. A lack of power can have a more severe impact when interpreting the linear regression models at WTP=$0/AFD (i.e., ΔC), because of the skewed nature of costs. Second, although regression diagnostics were done to assess the correctness of our models, they were not validated with data-splitting to ensure its adequacy as the sample was limited. Results will need to be replicated. Third, although not extreme, regression diagnostic highlighted skewness in data, particularly at low WTP when costs have a more considerable impact on the nb<sub>i</sub> distribution. A nonparametric method to obtain the p-values for the CEAC is bootstrapping. However, in addition to being able to adjust models, as underlined by Hoch et al., (2006), the net-benefit regression framework has the advantage of computing: (1) the INB, (2) the mean nb<sub>i</sub> of the control group (β<sub>0</sub>), the mean nb<sub>i</sub> of the experimental group (β<sub>0</sub> + β<sub>1</sub>) as well as regression information (residuals, R<sup>2</sup>, etc.) [<xref ref-type="bibr" rid="CR84">84</xref>]. Fourth, more than one individual in three had missing clinical or cost data at the 4-month post-treatment assessment, introducing a potential bias. The multiple imputation model included variables significantly associated with missingness and baseline variables, minimizing the effect of attrition on results. As no logical bounds or transformations were applied in the multiple imputation processes to prevent possibly biasing findings [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>], we examined the proportions of negative values of total cost after multiple imputation and these were minimal. Fifth, to this day, there is no recommendation as to the value of an anxiety-free day. The interaction between the intervention and the number of anxiety comorbidities was statistically significant at willingness to pay thresholds up to CAN $60/AFD. That being said, the importance of this finding will depend on the future societal value of an AFD. Sixth, due to the high number of statistical analyses, there is an increased risk for type I errors, but no correction was made due to this study’s exploratory nature. Finally, AFD represents a measure of the variation of anxiety symptoms over time. As quality-adjusted life years is a standard outcome in economic evaluation, representing both quantity and quality of life, future studies could assess the moderators of its association with tCBT on a longer time horizon with a measure responsive to change in a mental health context.</p>
              <p id="Par47">As for the generalizability of results, the following need to be considered. This study is a secondary data analysis from an RCT, carried out in a French-speaking Canadian province, for which participants were mostly white females self-reporting a favorable socioeconomic status. Future research on potential moderators affecting the cost-effectiveness of tCBT should consider a naturalistic study design factoring in contextual elements such as access to mental health care and including a more diverse sample. Also, the recruitment process was designed to represent the primary care sector in a public health system. It limits the generalization of results to other specialty and health system contexts. Moreover, the public healthcare context is to be considered when analyzing costs related to service use as most medical care and treatments are covered or partially covered, and insurance coverage may affect help-seeking behaviours [<xref ref-type="bibr" rid="CR87">87</xref>].</p>
            </sec>
            <sec id="Sec16" sec-type="conclusion">
              <title>Conclusion</title>
              <p id="Par48">The current study findings showed that increased anxiety disorder comorbidity influenced the cost-effectiveness of tCBT + TAU vs. TAU from a limited societal perspective. Evaluating the cost-effectiveness of tCBT added to treatment as usual in populations with different anxiety disorder comorbidities and settings is needed to improve timely access to quality mental health resources.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Electronic supplementary material</title>
              <sec id="Sec17">
                <p>Below is the link to the electronic supplementary material.</p>
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="12913_2023_9468_MOESM1_ESM.docx">
                      <caption>
                        <p>Supplementary Material 1: Supplementary methods appendix</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
                <p>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="12913_2023_9468_MOESM2_ESM.docx">
                      <caption>
                        <p>Supplementary Material 2: Supplementary results appendix</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>We would like to acknowledge the contribution of the three study sites in Quebec City, Laval and Sherbrooke for the essential support to the conduct of the trial. The three study sites provided in-kind contributions through the involvement of public sector psychologists and psychotherapists as co-therapists in tCBT treatment, the provision of office space in primary care settings for participants’ assessment and treatment delivery, and administrative support. We are grateful to all the patients that took part in the study. We would like to thank all the clinical evaluators and therapists who contributed to the recruitment and delivery of the intervention to study participants.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>AC: Methodology, Data curation, Software, Formal analysis, Writing-Original draft, Visualization, Writing-Review &amp; Editing. HMV: Conceptualization, Methodology, Formal analysis, Writing-Review &amp; Editing, Supervision, Funding acquisition. MDP: Conceptualization, Methodology, Writing-Review &amp; Editing, Supervision, Project administration, Investigation. Funding acquisition. PJN: Conceptualization, Methodology, Writing-Review &amp; Editing, Funding acquisition. PR: Conceptualization, Methodology, Writing-Review &amp; Editing, Supervision, Project administration, Investigation, Funding acquisition. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>The Canadian Institutes of Health Research funded this study (CIHR grants #334091 and 340410). For this project, Alexandra Chapdelaine received a doctoral training scholarship from the Fonds de Recherche en Santé du Québec [Quebec Health Research Fund] (254786).</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability</title>
              <p>The datasets generated and/or analysed during the current study are not publicly available due the multicentre ethical approval and the consent forms that do not allow for open access to data, but are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar11">
                <title>Ethics approval and consent to participate</title>
                <p id="Par251">All methods were performed in accordance with the relevant guidelines and regulations. Participants provided written informed consent at the initial pre-assignment information and evaluation session. The study was approved by the principal ethics review board (Comité d’éthique de la recherche du Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre hospitalier universitaire de Sherbrooke [Research Ethics Board of the Eastern Townships Health and Social Services Integrated University Center – University Hospital Center of Sherbrooke], #MP-22-2016-570) and the ethics review boards of the two other participating institutions (Comité d’éthique de la recherche de l’lnstitut Universitaire en santé mentale de Québec [Research Ethics Board of the Mental Health University Institute of Quebec], #2017–166; Comité scientifique et d’éthique de la recherche – CISSS de Laval [Research Scientific and Ethics Board – Health and Social Services Integrated Center of Laval], #2016–2017 / C54).</p>
              </notes>
              <notes id="FPar12">
                <title>Consent for publication</title>
                <p id="Par252">Not applicable.</p>
              </notes>
              <notes id="FPar1" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par69">Peter J. Norton is the developer of the tCBT protocol used for this study and receives royalties from Guilford Press for sales of <italic>Group Cognitive Therapy of Anxiety: A Transdiagnostic Treatment Manual</italic> [<xref ref-type="bibr" rid="CR30">30</xref>]. The authors declare that they have no other conflicting interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drummond</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Sculpher</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Torrance</surname>
                      <given-names>GW</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Stoddart</surname>
                      <given-names>GL</given-names>
                    </name>
                  </person-group>
                  <source>Methods for the economic evaluation of health care programmes</source>
                  <year>2005</year>
                  <edition>3</edition>
                  <publisher-loc>Oxford</publisher-loc>
                  <publisher-name>Oxford University Press</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zethraeus</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Johannesson</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jönsson</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Löthgren</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Tambour</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies</article-title>
                  <source>PharmacoEconomics</source>
                  <year>2003</year>
                  <volume>21</volume>
                  <fpage>39</fpage>
                  <lpage>48</lpage>
                  <pub-id pub-id-type="doi">10.2165/00019053-200321010-00003</pub-id>
                  <?supplied-pmid 12484802?>
                  <pub-id pub-id-type="pmid">12484802</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoch</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Briggs</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Willan</surname>
                      <given-names>AR</given-names>
                    </name>
                  </person-group>
                  <article-title>Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis</article-title>
                  <source>Health Econ</source>
                  <year>2002</year>
                  <volume>11</volume>
                  <fpage>415</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="doi">10.1002/hec.678</pub-id>
                  <?supplied-pmid 12112491?>
                  <pub-id pub-id-type="pmid">12112491</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoch</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Dewa</surname>
                      <given-names>CS</given-names>
                    </name>
                  </person-group>
                  <article-title>Advantages of the Net Benefit Regression Framework for economic evaluations of interventions in the Workplace</article-title>
                  <source>J Occup Environ Med</source>
                  <year>2014</year>
                  <volume>56</volume>
                  <fpage>441</fpage>
                  <lpage>5</lpage>
                  <pub-id pub-id-type="doi">10.1097/JOM.0000000000000130</pub-id>
                  <?supplied-pmid 24662952?>
                  <pub-id pub-id-type="pmid">24662952</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoch</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Hay</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Isaranuwatchai</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Thavorn</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Leighl</surname>
                      <given-names>NB</given-names>
                    </name>
                    <name>
                      <surname>Tu</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the canadian Cancer trials Group CO.17 trial</article-title>
                  <source>BMC Cancer</source>
                  <year>2019</year>
                  <volume>19</volume>
                  <fpage>552</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12885-019-5779-x</pub-id>
                  <?supplied-pmid 31174497?>
                  <pub-id pub-id-type="pmid">31174497</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stinnett</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Mullahy</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis</article-title>
                  <source>Med Decis Making</source>
                  <year>1998</year>
                  <volume>18</volume>
                  <issue>2suppl</issue>
                  <fpage>68</fpage>
                  <lpage>80</lpage>
                  <pub-id pub-id-type="doi">10.1177/0272989X98018002S09</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tambour</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zethraeus</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Johannesson</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>A note on confidence intervals in cost-effectiveness analysis</article-title>
                  <source>Int J Technol Assess Health Care</source>
                  <year>1998</year>
                  <volume>14</volume>
                  <fpage>467</fpage>
                  <lpage>71</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0266462300011442</pub-id>
                  <?supplied-pmid 9780533?>
                  <pub-id pub-id-type="pmid">9780533</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Katzman</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Bleau</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Blier</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Chokka</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kjernisted</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>van Ameringen</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <issue>Suppl 1</issue>
                  <fpage>1</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-244X-14-S1-S1</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <mixed-citation publication-type="other">2011; National Institute for Health and Care Excellence. Common mental health problems: identification and pathways to care [NICE Guideline No. 123], May. <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/cg123">https://www.nice.org.uk/guidance/cg123</ext-link>. Accessed 16 Jan 2023.</mixed-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Norton</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Transdiagnostic therapy</article-title>
                  <source>Psychiatr Clin North Am</source>
                  <year>2017</year>
                  <volume>40</volume>
                  <fpage>675</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.psc.2017.08.003</pub-id>
                  <?supplied-pmid 29080593?>
                  <pub-id pub-id-type="pmid">29080593</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reinholt</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Krogh</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of Transdiagnostic cognitive behaviour therapy for anxiety Disorders: a systematic review and Meta-analysis of published Outcome Studies</article-title>
                  <source>Cogn Behav Ther</source>
                  <year>2014</year>
                  <volume>43</volume>
                  <fpage>171</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="doi">10.1080/16506073.2014.897367</pub-id>
                  <?supplied-pmid 24646219?>
                  <pub-id pub-id-type="pmid">24646219</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <mixed-citation publication-type="other">García-Escalera J, Chorot P, Valiente RM, Reales JM, Sandín B. Efficacy of transdiagnostic cognitive-behavioral therapy for anxiety and depression in adults, children and adolescents: A meta-analysis. Revista de Psicopatología y Psicología Clínica. 2016;21:147–75.</mixed-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andersen</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Toner</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Bland</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>McMillan</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Effectiveness of transdiagnostic cognitive behaviour therapy for anxiety and depression in adults: a systematic review and meta-analysis</article-title>
                  <source>Behav Cogn Psychother</source>
                  <year>2016</year>
                  <volume>44</volume>
                  <fpage>673</fpage>
                  <lpage>90</lpage>
                  <pub-id pub-id-type="doi">10.1017/S1352465816000229</pub-id>
                  <?supplied-pmid 27301967?>
                  <pub-id pub-id-type="pmid">27301967</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Newby</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Twomey</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Yuan Li</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Andrews</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Transdiagnostic computerised cognitive behavioural therapy for depression and anxiety: a systematic review and meta-analysis</article-title>
                  <source>J Affect Disord</source>
                  <year>2016</year>
                  <volume>199</volume>
                  <fpage>30</fpage>
                  <lpage>41</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2016.03.018</pub-id>
                  <?supplied-pmid 27060430?>
                  <pub-id pub-id-type="pmid">27060430</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pearl</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Norton</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Transdiagnostic versus diagnosis specific cognitive behavioural therapies for anxiety: a meta-analysis</article-title>
                  <source>J Anxiety Disord</source>
                  <year>2017</year>
                  <volume>46</volume>
                  <fpage>11</fpage>
                  <lpage>24</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.janxdis.2016.07.004</pub-id>
                  <?supplied-pmid 27466074?>
                  <pub-id pub-id-type="pmid">27466074</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grochtdreis</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Brettschneider</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bjerregaard</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Bleich</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Boczor</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Härter</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cost-effectiveness analysis of collaborative treatment of late-life depression in primary care (GermanIMPACT)</article-title>
                  <source>Eur Psychiatry</source>
                  <year>2019</year>
                  <volume>57</volume>
                  <fpage>10</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.eurpsy.2018.12.007</pub-id>
                  <?supplied-pmid 30658275?>
                  <pub-id pub-id-type="pmid">30658275</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Simons</surname>
                      <given-names>CJP</given-names>
                    </name>
                    <name>
                      <surname>Drukker</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Evers</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>van Mastrigt</surname>
                      <given-names>GAPG</given-names>
                    </name>
                    <name>
                      <surname>Höhn</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kramer</surname>
                      <given-names>I</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Economic evaluation of an experience sampling method intervention in depression compared with treatment as usual using data from a randomized controlled trial</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <fpage>415</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12888-017-1577-7</pub-id>
                  <?supplied-pmid 29284448?>
                  <pub-id pub-id-type="pmid">29284448</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Egger</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Konnopka</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Beutel</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Herpertz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hiller</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Hoyer</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Short-term cost-effectiveness of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: results from the SOPHO-NET trial</article-title>
                  <source>J Affect Disord</source>
                  <year>2015</year>
                  <volume>180</volume>
                  <fpage>21</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2015.03.037</pub-id>
                  <?supplied-pmid 25879721?>
                  <pub-id pub-id-type="pmid">25879721</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Egger</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Konnopka</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Beutel</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Herpertz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hiller</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Hoyer</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-term cost-effectiveness of cognitive behavioral therapy versus psychodynamic therapy in social anxiety disorder</article-title>
                  <source>Depress Anxiety</source>
                  <year>2016</year>
                  <volume>33</volume>
                  <fpage>1114</fpage>
                  <lpage>22</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.22540</pub-id>
                  <?supplied-pmid 27428816?>
                  <pub-id pub-id-type="pmid">27428816</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <mixed-citation publication-type="other">Brandenburg A. Cognitive behavioral therapy for anxiety Disorders-Predictors of Outcome a systematic review. Universiteit Twente; 2017.</mixed-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cuijpers</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Karyotaki</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Reijnders</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Huibers</surname>
                      <given-names>MJH</given-names>
                    </name>
                  </person-group>
                  <article-title>Who benefits from psychotherapies for adult depression? A meta-analytic update of the evidence</article-title>
                  <source>Cogn Behav Ther</source>
                  <year>2018</year>
                  <volume>47</volume>
                  <fpage>91</fpage>
                  <lpage>106</lpage>
                  <pub-id pub-id-type="doi">10.1080/16506073.2017.1420098</pub-id>
                  <?supplied-pmid 29345530?>
                  <pub-id pub-id-type="pmid">29345530</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Eskildsen</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hougaard</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Rosenberg</surname>
                      <given-names>NK</given-names>
                    </name>
                  </person-group>
                  <article-title>Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: a systematic review</article-title>
                  <source>Nord J Psychiatry</source>
                  <year>2010</year>
                  <volume>64</volume>
                  <fpage>94</fpage>
                  <lpage>105</lpage>
                  <pub-id pub-id-type="doi">10.3109/08039480903426929</pub-id>
                  <?supplied-pmid 20055730?>
                  <pub-id pub-id-type="pmid">20055730</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Amati</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Banks</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Greenfield</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictors of outcomes for patients with common mental health disorders receiving psychological therapies in community settings: a systematic review</article-title>
                  <source>J Public Health (Bangkok)</source>
                  <year>2018</year>
                  <volume>40</volume>
                  <fpage>e375</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.1093/pubmed/fdx168</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>González-Blanch</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Muñoz-Navarro</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Medrano</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Moriana</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Ruiz-Rodríguez</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Cano-Vindel</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Moderators and predictors of treatment outcome in transdiagnostic group cognitive-behavioral therapy for primary care patients with emotional disorders</article-title>
                  <source>Depress Anxiety</source>
                  <year>2021</year>
                  <volume>38</volume>
                  <fpage>757</fpage>
                  <lpage>67</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.23164</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Marchand</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Reinharz</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Cloutier</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Mainguy</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>JM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Healthcare utilization following cognitive-behavioral treatment for panic disorder with agoraphobia</article-title>
                  <source>Cogn Behav Ther</source>
                  <year>2005</year>
                  <volume>34</volume>
                  <fpage>79</fpage>
                  <lpage>88</lpage>
                  <pub-id pub-id-type="doi">10.1080/16506070510008443</pub-id>
                  <?supplied-pmid 15986784?>
                  <pub-id pub-id-type="pmid">15986784</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ikic</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Belanger</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bouchard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gosselin</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Langlois</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Labrecque</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduction in costs after treating comorbid panic disorder with Agoraphobia and generalized anxiety disorder</article-title>
                  <source>J Mental Health Policy Econ</source>
                  <year>2017</year>
                  <volume>20</volume>
                  <fpage>11</fpage>
                  <lpage>20</lpage>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <mixed-citation publication-type="other">van Nieuwenhuyse H, Dumas M-E. Rapport d’appréciation de la performance du système de santé et de services sociaux [Report on the performance of the health and social services system]. Commissaire à la santé et au bien-être du Québec; 2012.</mixed-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fleury</surname>
                      <given-names>M-J</given-names>
                    </name>
                    <name>
                      <surname>Grenier</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <source>État de la situation sur la santé mentale au Québec et réponse du système de santé et de services sociaux [The state of mental health in Quebec and the response of the health and social services system]</source>
                  <year>2012</year>
                  <publisher-loc>Québec, Canada</publisher-loc>
                  <publisher-name>Gouvernement du Québec</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <mixed-citation publication-type="other">Chapdelaine A, Vasiliadis HM, Provencher MD, Norton PJ, Roberge P. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders v. treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data. Psychol Med. 2023 Jan 25:1–13. 10.1017/S0033291722003920. Epub ahead of print.</mixed-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Norton</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <source>Group cognitive-behavioral therapy of anxiety: a Transdiagnostic Treatment Manual</source>
                  <year>2012</year>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>The Guilford Press</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Provencher</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Gosselin</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Vasiliadis</surname>
                      <given-names>H-M</given-names>
                    </name>
                    <name>
                      <surname>Gaboury</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Benoît</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <fpage>320</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12888-018-1898-1</pub-id>
                  <?supplied-pmid 30285672?>
                  <pub-id pub-id-type="pmid">30285672</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Provencher</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Gaboury</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Vasiliadis</surname>
                      <given-names>H-M</given-names>
                    </name>
                    <name>
                      <surname>Benoit</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Carrier</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Group transdiagnostic cognitive-behaviour therapy for anxiety disorders: a pragmatic randomized clinical trial</article-title>
                  <source>Psychol Med</source>
                  <year>2022</year>
                  <volume>52</volume>
                  <fpage>2460</fpage>
                  <lpage>70</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0033291720004316</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <mixed-citation publication-type="other">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM–5). 5th edition. Washington, D.C.: Author; 2013.</mixed-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <mixed-citation publication-type="other">Brown TA, Barlow DH. Anxiety and Related Disorders Interview Schedule for DSM-5 - Adult and Lifetime Version: Clinician Manual. Oxford Uni. 2014.</mixed-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Marchand</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Reinharz</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Savard</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive-behavioral treatment for panic disorder with Agoraphobia: a Randomized, controlled trial and cost-effectiveness analysis</article-title>
                  <source>Behav Modif</source>
                  <year>2008</year>
                  <volume>32</volume>
                  <fpage>333</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="doi">10.1177/0145445507309025</pub-id>
                  <?supplied-pmid 18391051?>
                  <pub-id pub-id-type="pmid">18391051</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <mixed-citation publication-type="other">Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018. PharmacoEconomics 2020 38:10. 2020;38:1135–45.</mixed-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reinharz</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Lesage</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Contandriopoulos</surname>
                      <given-names>AP</given-names>
                    </name>
                  </person-group>
                  <article-title>Cost-effectiveness analysis of psychiatric deinstitutionalization</article-title>
                  <source>Can J Psychiatry</source>
                  <year>2000</year>
                  <volume>45</volume>
                  <fpage>533</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1177/070674370004500603</pub-id>
                  <?supplied-pmid 10986570?>
                  <pub-id pub-id-type="pmid">10986570</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <mixed-citation publication-type="other">Statistics Canada. Consumer Price Index, monthly, not seasonally adjusted. 2020. <ext-link ext-link-type="uri" xlink:href="https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=1810000401#timeframe">https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=1810000401#timeframe</ext-link>. Accessed 29 Jun 2020.</mixed-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lave</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Schulberg</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Kamlet</surname>
                      <given-names>MS</given-names>
                    </name>
                  </person-group>
                  <article-title>Cost-effectiveness of treatments for major depression in primary care practice</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <year>1998</year>
                  <volume>55</volume>
                  <fpage>645</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="doi">10.1001/archpsyc.55.7.645</pub-id>
                  <?supplied-pmid 9672056?>
                  <pub-id pub-id-type="pmid">9672056</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vannoy</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Arean</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Unützer</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Advantages of using estimated Depression-Free days for evaluating treatment efficacy</article-title>
                  <source>Psychiatric Serv</source>
                  <year>2010</year>
                  <volume>61</volume>
                  <fpage>160</fpage>
                  <pub-id pub-id-type="doi">10.1176/ps.2010.61.2.160</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beck</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <source>Beck anxiety Inventory Manual</source>
                  <year>1993</year>
                  <publisher-loc>San Antonio, TX</publisher-loc>
                  <publisher-name>Psychological Corporation</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steele</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Dewa</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>KLK</given-names>
                    </name>
                    <name>
                      <surname>Education Level</surname>
                    </name>
                  </person-group>
                  <article-title>Income level and Mental Health Services Use in Canada: Associations and Policy Implications</article-title>
                  <source>Healthc Policy</source>
                  <year>2007</year>
                  <volume>3</volume>
                  <fpage>96</fpage>
                  <?supplied-pmid 19305758?>
                  <pub-id pub-id-type="pmid">19305758</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gulliver</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Griffiths</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Christensen</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Perceived barriers and facilitators to mental health help-seeking in young people: a systematic review</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2010</year>
                  <volume>10</volume>
                  <fpage>113</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-244X-10-113</pub-id>
                  <?supplied-pmid 21192795?>
                  <pub-id pub-id-type="pmid">21192795</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harvey</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Gumport</surname>
                      <given-names>NB</given-names>
                    </name>
                  </person-group>
                  <article-title>Evidence-based psychological treatments for mental disorders: modifiable barriers to access and possible solutions</article-title>
                  <source>Behav Res Ther</source>
                  <year>2015</year>
                  <volume>68</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.brat.2015.02.004</pub-id>
                  <?supplied-pmid 25768982?>
                  <pub-id pub-id-type="pmid">25768982</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mojtabai</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Trends in contacts with mental health professionals and cost barriers to mental health care among adults with significant psychological distress in the United States: 1997–2002</article-title>
                  <source>Am J Public Health</source>
                  <year>2005</year>
                  <volume>95</volume>
                  <fpage>2009</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="doi">10.2105/AJPH.2003.037630</pub-id>
                  <?supplied-pmid 16195533?>
                  <pub-id pub-id-type="pmid">16195533</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Walker</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Cummings</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Hockenberry</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Druss</surname>
                      <given-names>BG</given-names>
                    </name>
                  </person-group>
                  <article-title>Insurance status, use of mental health services, and unmet need for mental health care in the united states</article-title>
                  <source>Psychiatric Serv</source>
                  <year>2015</year>
                  <volume>66</volume>
                  <fpage>578</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="doi">10.1176/appi.ps.201400248</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Perreault</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lafortune</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Laverdure</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Chartier-Otis</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bélanger</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Marchand</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Barriers to treatment access reported by people with anxiety disorders</article-title>
                  <source>Can J Psychiatry</source>
                  <year>2013</year>
                  <volume>58</volume>
                  <fpage>300</fpage>
                  <lpage>5</lpage>
                  <pub-id pub-id-type="doi">10.1177/070674371305800508</pub-id>
                  <?supplied-pmid 23756290?>
                  <pub-id pub-id-type="pmid">23756290</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moroz</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Moroz</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>D’Angelo</surname>
                      <given-names>MS</given-names>
                    </name>
                  </person-group>
                  <article-title>Mental health services in Canada: barriers and cost-effective solutions to increase access</article-title>
                  <source>Healthc Manage Forum</source>
                  <year>2020</year>
                  <volume>33</volume>
                  <fpage>282</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1177/0840470420933911</pub-id>
                  <?supplied-pmid 32613867?>
                  <pub-id pub-id-type="pmid">32613867</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Simo</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Bamvita</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Caron</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Fleury</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictors of mental health service use among individuals with high psychological distress and mental disorders</article-title>
                  <source>Psychiatry Res</source>
                  <year>2018</year>
                  <volume>270</volume>
                  <fpage>1122</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.psychres.2018.10.019</pub-id>
                  <?supplied-pmid 30360914?>
                  <pub-id pub-id-type="pmid">30360914</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Plaisier</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Beekman</surname>
                      <given-names>ATF</given-names>
                    </name>
                    <name>
                      <surname>de Graaf</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Smit</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>van Dyck</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Penninx</surname>
                      <given-names>BWJH</given-names>
                    </name>
                  </person-group>
                  <article-title>Work functioning in persons with depressive and anxiety disorders: the role of specific psychopathological characteristics</article-title>
                  <source>J Affect Disord</source>
                  <year>2010</year>
                  <volume>125</volume>
                  <fpage>198</fpage>
                  <lpage>206</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2010.01.072</pub-id>
                  <?supplied-pmid 20185180?>
                  <pub-id pub-id-type="pmid">20185180</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Higgins</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Chambers</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Major</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Durham</surname>
                      <given-names>RC</given-names>
                    </name>
                  </person-group>
                  <article-title>Healthcare costs and quality of life associated with the long-term outcome of anxiety disorders</article-title>
                  <source>Anxiety Stress Coping</source>
                  <year>2021</year>
                  <volume>34</volume>
                  <fpage>228</fpage>
                  <lpage>41</lpage>
                  <pub-id pub-id-type="doi">10.1080/10615806.2020.1839731</pub-id>
                  <?supplied-pmid 33108887?>
                  <pub-id pub-id-type="pmid">33108887</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marciniak</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Lage</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Dunayevich</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Russell</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Bowman</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Landbloom</surname>
                      <given-names>RP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The cost of treating anxiety: the medical and demographic correlates that impact total medical costs</article-title>
                  <source>Depress Anxiety</source>
                  <year>2005</year>
                  <volume>21</volume>
                  <fpage>178</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.20074</pub-id>
                  <?supplied-pmid 16075454?>
                  <pub-id pub-id-type="pmid">16075454</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salomonsson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Santoft</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Lindsäter</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ejeby</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ingvar</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Öst</surname>
                      <given-names>LG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Predictors of outcome in guided self-help cognitive behavioural therapy for common mental disorders in primary care</article-title>
                  <source>Cogn Behav Ther</source>
                  <year>2020</year>
                  <volume>49</volume>
                  <fpage>455</fpage>
                  <lpage>74</lpage>
                  <pub-id pub-id-type="doi">10.1080/16506073.2019.1669701</pub-id>
                  <?supplied-pmid 31638472?>
                  <pub-id pub-id-type="pmid">31638472</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stuhldreher</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Leibing</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Leichsenring</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Beutel</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Herpertz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hoyer</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The costs of social anxiety disorder: the role of symptom severity and comorbidities</article-title>
                  <source>J Affect Disord</source>
                  <year>2014</year>
                  <volume>165</volume>
                  <fpage>87</fpage>
                  <lpage>94</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2014.04.039</pub-id>
                  <?supplied-pmid 24882183?>
                  <pub-id pub-id-type="pmid">24882183</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barsky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Orav</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Bates</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <year>2005</year>
                  <volume>62</volume>
                  <fpage>903</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1001/archpsyc.62.8.903</pub-id>
                  <?supplied-pmid 16061768?>
                  <pub-id pub-id-type="pmid">16061768</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kariuki-Nyuthe</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>DJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Anxiety and related disorders and physical illness</article-title>
                  <source>Key Issues in Mental Health</source>
                  <year>2015</year>
                  <volume>179</volume>
                  <fpage>81</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1159/000365538</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bandelow</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Reitt</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Röver</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Michaelis</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Görlich</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wedekind</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of treatments for anxiety disorders: a meta-analysis</article-title>
                  <source>Int Clin Psychopharmacol</source>
                  <year>2015</year>
                  <volume>30</volume>
                  <fpage>183</fpage>
                  <lpage>92</lpage>
                  <pub-id pub-id-type="doi">10.1097/YIC.0000000000000078</pub-id>
                  <?supplied-pmid 25932596?>
                  <pub-id pub-id-type="pmid">25932596</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <mixed-citation publication-type="other">Honaker J, King G, Blackwell M, Amelia II. A program for missing data. R package version 1.7.6. 2019. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=Amelia">https://CRAN.R-project.org/package=Amelia</ext-link></mixed-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Honaker</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>King</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Blackwell</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>AMELIA II: a program for Missing Data</article-title>
                  <source>J Stat Softw</source>
                  <year>2011</year>
                  <volume>45</volume>
                  <fpage>1</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="doi">10.18637/jss.v045.i07</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <mixed-citation publication-type="other">Kleinke K, Reinecke J, Salfrán D, Spiess M. Applied multiple imputation: advantages, pitfalls, new developments and applications in R. Springer; 2020.</mixed-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rodwell</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Romaniuk</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Carlin</surname>
                      <given-names>JB</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of methods for imputing limited-range variables: a simulation study</article-title>
                  <source>BMC Med Res Methodol</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2288-14-57</pub-id>
                  <pub-id pub-id-type="pmid">24383436</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <mixed-citation publication-type="other">IBM. IBM SPSS Statistics Algorithms. 2020.</mixed-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Hout</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Al</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Gordon</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Rutten</surname>
                      <given-names>FFH</given-names>
                    </name>
                  </person-group>
                  <article-title>Costs, effects and C/E-ratios alongside a clinical trial</article-title>
                  <source>Health Econ</source>
                  <year>1994</year>
                  <volume>3</volume>
                  <fpage>309</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="doi">10.1002/hec.4730030505</pub-id>
                  <?supplied-pmid 7827647?>
                  <pub-id pub-id-type="pmid">7827647</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jager</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Zoccali</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>MacLeod</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Dekker</surname>
                      <given-names>FW</given-names>
                    </name>
                  </person-group>
                  <article-title>Confounding: what it is and how to deal with it</article-title>
                  <source>Kidney Int</source>
                  <year>2008</year>
                  <volume>73</volume>
                  <fpage>256</fpage>
                  <lpage>60</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.ki.5002650</pub-id>
                  <?supplied-pmid 17978811?>
                  <pub-id pub-id-type="pmid">17978811</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <mixed-citation publication-type="other">Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd edition. Philadelphia: Wolters Kluwer/Lippincott Williams &amp; Wilkins; 2018.</mixed-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>King</surname>
                      <given-names>PS</given-names>
                    </name>
                  </person-group>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Gellman</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>JR</given-names>
                    </name>
                  </person-group>
                  <article-title>Moderators/Moderating factors</article-title>
                  <source>Encyclopedia of behavioral medicine</source>
                  <year>2013</year>
                  <publisher-loc>New York, NY</publisher-loc>
                  <publisher-name>Springer New York</publisher-name>
                  <fpage>1256</fpage>
                  <lpage>8</lpage>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Carlin</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>KJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Model checking in multiple imputation: an overview and case study</article-title>
                  <source>Emerg Themes Epidemiol</source>
                  <year>2017</year>
                  <volume>14</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12982-017-0062-6</pub-id>
                  <pub-id pub-id-type="pmid">28184234</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jacoby</surname>
                      <given-names>WG</given-names>
                    </name>
                  </person-group>
                  <article-title>Loess: a nonparametric, graphical tool for depicting relationships between variables</article-title>
                  <source>Elect Stud</source>
                  <year>2000</year>
                  <volume>19</volume>
                  <fpage>577</fpage>
                  <lpage>613</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0261-3794(99)00028-1</pub-id>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cain</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Yuan</surname>
                      <given-names>K-H</given-names>
                    </name>
                  </person-group>
                  <article-title>Univariate and multivariate skewness and kurtosis for measuring nonnormality: prevalence, influence and estimation</article-title>
                  <source>Behav Res Methods 2016</source>
                  <year>2016</year>
                  <volume>49</volume>
                  <fpage>5</fpage>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>H-Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis</article-title>
                  <source>Restor Dent Endod</source>
                  <year>2013</year>
                  <volume>38</volume>
                  <fpage>52</fpage>
                  <pub-id pub-id-type="doi">10.5395/rde.2013.38.1.52</pub-id>
                  <?supplied-pmid 23495371?>
                  <pub-id pub-id-type="pmid">23495371</pub-id>
                </element-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <mixed-citation publication-type="other">Kutner MH, Nachtsheim CJ, Neter J, Li W. Applied Linear Statistical Models. 5th edition. New York: McGraw-Hill/Irwin; 2005.</mixed-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Velleman</surname>
                      <given-names>PF</given-names>
                    </name>
                    <name>
                      <surname>Welsch</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficient Computing of Regression Diagnostics</article-title>
                  <source>Am Stat</source>
                  <year>1981</year>
                  <volume>35</volume>
                  <fpage>234</fpage>
                </element-citation>
              </ref>
              <ref id="CR73">
                <label>73.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Besley</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Kuh</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Welsch</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <source>Regression Diagnostics: identifying Influential Data and sources of Collinearity</source>
                  <year>1980</year>
                  <publisher-loc>Hoboken, New Jersey</publisher-loc>
                  <publisher-name>John Wiley &amp; Sons</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR74">
                <label>74.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fox</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <source>Regression diagnostic</source>
                  <year>1991</year>
                  <publisher-loc>Thousand Oaks, California</publisher-loc>
                  <publisher-name>Sage Publications, Inc</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR75">
                <label>75.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cook</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Weisberg</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <source>Residuals and influence in regression</source>
                  <year>1982</year>
                  <publisher-loc>New York, NY</publisher-loc>
                  <publisher-name>Chapman and Hall</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR76">
                <label>76.</label>
                <mixed-citation publication-type="other">Horenstein A, Heimberg RG. Anxiety disorders and healthcare utilization: A systematic review. Clin Psychol Rev. 2020;81.</mixed-citation>
              </ref>
              <ref id="CR77">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Norton</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Provencher</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Kilby</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Roberge</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of group transdiagnostic cognitive-behavior therapy for anxiety disorders on comorbid diagnoses: results from a pragmatic randomized clinical trial in primary care</article-title>
                  <source>Depress Anxiety</source>
                  <year>2021</year>
                  <volume>38</volume>
                  <fpage>749</fpage>
                  <lpage>56</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.23184</pub-id>
                </element-citation>
              </ref>
              <ref id="CR78">
                <label>78.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Norton</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Barrera</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Mathew</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Chamberlain</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Szafranski</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Reddy</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of transdiagnostic cbt for anxiety disorders on comorbid diagnoses</article-title>
                  <source>Depress Anxiety</source>
                  <year>2013</year>
                  <volume>30</volume>
                  <fpage>168</fpage>
                  <lpage>73</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.22018</pub-id>
                  <?supplied-pmid 23212696?>
                  <pub-id pub-id-type="pmid">23212696</pub-id>
                </element-citation>
              </ref>
              <ref id="CR79">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Jonge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Roest</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>CCW</given-names>
                    </name>
                    <name>
                      <surname>Florescu</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Bromet</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys</article-title>
                  <source>Depress Anxiety</source>
                  <year>2016</year>
                  <volume>33</volume>
                  <fpage>1155</fpage>
                  <lpage>77</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.22572</pub-id>
                  <?supplied-pmid 27775828?>
                  <pub-id pub-id-type="pmid">27775828</pub-id>
                </element-citation>
              </ref>
              <ref id="CR80">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stein</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>CCW</given-names>
                    </name>
                    <name>
                      <surname>Roest</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>de Jonge</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Aguilar-Gaxiola</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Al-Hamzawi</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The cross-national epidemiology of social anxiety disorder: data from the World Mental Health Survey Initiative</article-title>
                  <source>BMC Med</source>
                  <year>2017</year>
                  <volume>15</volume>
                  <fpage>143</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12916-017-0889-2</pub-id>
                  <?supplied-pmid 28756776?>
                  <pub-id pub-id-type="pmid">28756776</pub-id>
                </element-citation>
              </ref>
              <ref id="CR81">
                <label>81.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roest</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>de Vries</surname>
                      <given-names>YA</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>CCW</given-names>
                    </name>
                    <name>
                      <surname>Wittchen</surname>
                      <given-names>H-U</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Adamowski</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health surveys</article-title>
                  <source>Depress Anxiety</source>
                  <year>2019</year>
                  <volume>36</volume>
                  <fpage>499</fpage>
                  <lpage>510</lpage>
                  <pub-id pub-id-type="doi">10.1002/da.22885</pub-id>
                  <?supplied-pmid 30726581?>
                  <pub-id pub-id-type="pmid">30726581</pub-id>
                </element-citation>
              </ref>
              <ref id="CR82">
                <label>82.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ruscio</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Hallion</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>CCW</given-names>
                    </name>
                    <name>
                      <surname>Aguilar-Gaxiola</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Al-Hamzawi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Alonso</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe</article-title>
                  <source>JAMA Psychiatry</source>
                  <year>2017</year>
                  <volume>74</volume>
                  <fpage>465</fpage>
                  <lpage>75</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.0056</pub-id>
                  <?supplied-pmid 28297020?>
                  <pub-id pub-id-type="pmid">28297020</pub-id>
                </element-citation>
              </ref>
              <ref id="CR83">
                <label>83.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Klein Hofmeijer-Sevink</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Batelaan</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>van Megen</surname>
                      <given-names>HJGM</given-names>
                    </name>
                    <name>
                      <surname>Penninx</surname>
                      <given-names>BW</given-names>
                    </name>
                    <name>
                      <surname>Cath</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>van den Hout</surname>
                      <given-names>MA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and anxiety (NESDA)</article-title>
                  <source>J Affect Disord</source>
                  <year>2012</year>
                  <volume>137</volume>
                  <fpage>106</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jad.2011.12.008</pub-id>
                  <pub-id pub-id-type="pmid">22240085</pub-id>
                </element-citation>
              </ref>
              <ref id="CR84">
                <label>84.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoch</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Rockx</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Krahn</surname>
                      <given-names>AD</given-names>
                    </name>
                  </person-group>
                  <article-title>Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of “community acquired” syncope</article-title>
                  <source>BMC Health Serv Res</source>
                  <year>2006</year>
                  <volume>6</volume>
                  <fpage>68</fpage>
                  <pub-id pub-id-type="doi">10.1186/1472-6963-6-68</pub-id>
                  <?supplied-pmid 16756680?>
                  <pub-id pub-id-type="pmid">16756680</pub-id>
                </element-citation>
              </ref>
              <ref id="CR85">
                <label>85.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Toward best Practices in analyzing datasets with Missing Data: comparisons and recommendations</article-title>
                  <source>J Marriage Fam</source>
                  <year>2011</year>
                  <volume>73</volume>
                  <fpage>926</fpage>
                  <lpage>45</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1741-3737.2011.00861.x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR86">
                <label>86.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Von Hippel</surname>
                      <given-names>PT</given-names>
                    </name>
                  </person-group>
                  <article-title>How to impute interactions, squares, and other transformed variables</article-title>
                  <source>Sociol Methodol</source>
                  <year>2009</year>
                  <volume>39</volume>
                  <fpage>265</fpage>
                  <lpage>91</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1467-9531.2009.01215.x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR87">
                <label>87.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ridic</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Gleason</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ridic</surname>
                      <given-names>O</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparisons of Health Care Systems in the United States, Germany and Canada</article-title>
                  <source>Materia Socio Medica</source>
                  <year>2012</year>
                  <volume>24</volume>
                  <fpage>112</fpage>
                  <pub-id pub-id-type="doi">10.5455/msm.2012.24.112-120</pub-id>
                  <?supplied-pmid 23678317?>
                  <pub-id pub-id-type="pmid">23678317</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
